Drug:  | 
         MP470  | 
       |||
|---|---|---|---|---|
Trial:  | 
         MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma  | 
       |||
| Conditions: | Advanced Stage Solid Tumors | |||
Trial Status:  | 
         Terminated  | 
       |||
TGen Clinical Research Services10460 N. 92nd Street, Suite 206       | 
      
Principal Investigator:  | 
        Daniel D. Hoff, MD | 
|---|---|
Contact:  | 
        TGen Clinical Research Services Patient Care Coordinator 10460 N. 92nd Street, Suite 206 Scottsdale, AZ 85258 Office 480-323-1339 Fax 480-323-1259 jingold@shc.org | 
Activation Status of this Site:  | 
        Closed | 
Notes about this Site:  | 
        |
 TGen Clinical Research Services Website:  | 
        http://www.tgen.org/research/index.cfm?pageid=1085 | 
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.